PredictImmune is a developer of prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases. The company aims to develop and commercialize a series of biomarker tests to guide physicians in the treatment of patients with immune-mediated disease, through prediction of long-term clinical prognosis.